治疗前代谢PET参数对同步放化疗后代谢完全缓解的宫颈癌患者的预后价值
回顾性分析61例同步放化疗后F-FDG PET达代谢完全缓解的宫颈癌患者,测量治疗前原发肿瘤及转移淋巴结的SUVmax、MTV、TLG。随访中11例(18.0%)复发、12例(19.7%)死亡;转移淋巴结SUVmax、MTV、TLG及总TLG可预测无病生存,淋巴结SUVmax可预测总生存,腹主动脉旁淋巴结转移与两者均相关。
要点
- 治疗前转移淋巴结SUVmax、MTV、TLG及总TLG可预测同步放化疗后代谢完全缓解患者的无病生存。
- 转移淋巴结SUVmax可预测总生存,腹主动脉旁淋巴结转移与无病生存和总生存均相关。
- 多因素分析中无病生存的最佳预测因子为淋巴结SUVmax,总生存的最佳预测因子为腹主动脉旁淋巴结转移。
核心结论
- 转移淋巴结的SUVmax或MTV等代谢PET参数可能作为局部晚期宫颈癌患者经根治性同步放化疗后达代谢完全缓解后复发或死亡的替代预后标志物。
研究设计与样本
- 回顾性分析61例在同步放化疗后F-FDG PET上达到代谢完全缓解的宫颈癌患者,测量治疗前PET的原发肿瘤及转移淋巴结SUVmax、MTV、TLG以及总MTV和总TLG,并进行无病生存和总生存分析。
主要发现
- 随访期间11例(18.0%)出现宫颈癌复发,12例(19.7%)死亡。
- 转移淋巴结的SUVmax、MTV、TLG及总TLG可显著预测无病生存,淋巴结SUVmax可预测总生存。
- 腹主动脉旁淋巴结转移与无病生存和总生存均显著相关。
- 多因素分析中,淋巴结SUVmax和腹主动脉旁淋巴结转移是无病生存的预后因素,最佳预测因子为淋巴结SUVmax。
- 多因素分析中,淋巴结MTV和腹主动脉旁淋巴结转移是总生存的显著预后因素,最佳预测因子为腹主动脉旁淋巴结转移。
临床怎么用
- 原文结论认为转移淋巴结的SUVmax或MTV等代谢PET参数可能作为局部晚期宫颈癌患者达代谢完全缓解后复发或死亡的替代预后标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cervical cancer may recur after concurrent chemoradiotherapy (CCRT), even in patients with metabolic complete response (mCR) on post-CCRT F-FDG PET. We retrospectively analyzed the value of metabolic parameters, measured by pretreatment PET, as prognostic factors for predicting recurrence and death in cervical cancer patients with mCR. METHODS: In 61 patients who reached mCR on post-CCRT, metabolic PET parameters including SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumors, as well as those of the metastatic lymph nodes, were measured by pre-CCRT PET. Total MTV and total TLG were also measured from primary tumors and metastatic lymph nodes. Survival analyses for disease-free survival (DFS) and overall survival (OS) were performed. RESULTS: Eleven patients (18.0%) presented with recurrence of cervical cancer, and 12 (19.7%) died during follow-up. SUVmax, MTV, TLG of metastatic lymph nodes, and total TLG could significantly predict DFS, and nodal SUVmax could predict OS. Para-aortic lymph node metastasis also significantly correlated with both DFS and OS. In multivariate analysis, nodal SUVmax and para-aortic lymph nodes metastasis were prognostic factors for DFS, and the best predictor was nodal SUVmax. For OS, nodal MTV and para-aortic lymph node metastasis were significant prognostic factors in multivariate analysis, and the best predictor was para-aortic lymph node metastasis. CONCLUSIONS: Metabolic PET parameters, SUVmax or MTV values of metastatic lymph nodes, may be surrogate prognostic markers for recurrence or death in patients with locally advanced cervical cancer who reached mCR after definitive CCRT.
引用
- Son SH, Jeong SY, Chong GO, et al. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy. Clin Nucl Med. 2018. PMID: 30036243. doi:10.1097/RLU.0000000000002188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。